Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA InfectionPHARMACEUTICSIF5.52023-08-310OAAI
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections (vol 65, e00316-21, 2021)ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52022-11-150OA
Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial HypertensionJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82022-10-013OAAI
Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertensionEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72022-02-016OAAI
Strategies to Overcome Biological Barriers Associated with Pulmonary Drug DeliveryPHARMACEUTICSIF5.52022-01-2721OAAI
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections用于治疗持续耐甲氧西林金黄色葡萄球菌感染的新型吸入脂糖肽的开发和临床前评估ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52021-06-178OAAI
Treprostinil palmitil, an inhaled long-acting pulmonary vasodilator, does not show tachyphylaxis with daily dosing in ratsPULMONARY PHARMACOLOGY & THERAPEUTICSIF2.82021-02-013OAAI
An overview of the biology of a long-acting inhaled treprostinil prodrugPULMONARY PHARMACOLOGY & THERAPEUTICSIF2.82020-12-0113OAAI
Comparison of Treprostinil Palmitil Inhalation Suspension (TPIS) or Oral Sildenafil (Sild) in a Sugen/Hypoxia Rat Model of PAHEUROPEAN RESPIRATORY JOURNALIF212020-10-280PRE
No evidence of desensitization to repeat dosing with treprostinil palmitil inhalation suspension (TPIS) for 32-consecutive days in hypoxia-challenged telemetered ratsEUROPEAN RESPIRATORY JOURNALIF212020-10-280PRE
Cough and airway irritation with inhaled treprostinil does not involve activation of laryngeal reflexes.EUROPEAN RESPIRATORY JOURNALIF212018-11-192PRE
Inhaled hexadecyl-treprostinil provides pulmonary vasodilator activity at significantly lower plasma concentrations than infused treprostinilPULMONARY PHARMACOLOGY & THERAPEUTICSIF2.82018-04-0118OAAI
Inhalation of dry powder INS1009 (DP-INS1009) does not activate the cough reflex in guinea pigs: a comparison with nebulized treprostinilEUROPEAN RESPIRATORY JOURNALIF212017-12-061PRE
Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator ProdrugJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82017-12-0125OAAI
Inhaled INS1009 demonstrates localized pulmonary vasodilation activityEUROPEAN RESPIRATORY JOURNALIF212016-11-081PRE
Evaluation of [111In]-Labeled Zinc-Dipicolylamine Tracers for SPECT Imaging of Bacterial InfectionMOLECULAR IMAGING AND BIOLOGYIF2.52014-08-1322OAAI
Library Synthesis, Screening, and Discovery of Modified Zinc(II)-Bis(dipicolylamine) Probe for Enhanced Molecular Imaging of Cell DeathBIOCONJUGATE CHEMISTRYIF3.92014-03-1340OAAI
19F NMR indicator displacement assay using a synthetic receptor with appended paramagnetic relaxation agentCHEMICAL COMMUNICATIONSIF4.22014-01-0113OAAI
Design, synthesis, and DNA binding characteristics of a group of orthogonally positioned diamino, N-formamido, pyrrole- and imidazole-containing polyamidesBIOORGANIC & MEDICINAL CHEMISTRYIF32013-07-014PRE
Affinity and kinetic modulation of polyamideDNA interactions by N-modification of the heterocyclesBIOPOLYMERSIF3.22013-05-251OAAI